Back to search
FDAFDA · Food and drugs·Recall number D-175-2013

buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217

Published March 6, 2013 · Recall initiated: January 4, 2013

Summary

FDA records drug Class III recall D-175-2013, published March 6, 2013 and initiated January 4, 2013. Recalling firm: Actavis Pharmaceuticals; Status: Terminated; Reported quantity: 14,856 bottles; Lot: Lot CB1D05A,. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Actavis Pharmaceuticals
Distributor
Nationwide
Lot
Lot CB1D05A,
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was buPROPion Hydrochloride Extended - Release Tablets (XL) 300 mg, 30 tablet bottles, Rx Only, NDC 67767-142-30 Actavis Distributed by: Actavis South Atlantic LLC Sunrise, FL 33325 Packaged by by: America Health Packaging Columbus, OH 43217 recalled?

Yes. FDA published recall D-175-2013 on March 6, 2013. Reported hazard: Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter